
|Articles|April 9, 2018
What’s your digital style?
Are you an iPhone user? Or does your allegiance belong to Android? Can’t resist the lure of Pinterest or are you always checking your Twitter feed? We want to hear how you interact with the digital world.
Advertisement
Are you an iPhone user? Or does your allegiance belong to Android? Can’t resist the lure of Pinterest or are you always checking your Twitter feed? We want to hear how you interact with the digital world.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
JAK Inhibitors Show Comparable Safety to TNF Antagonists
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5


















